Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial
Vaccine, ISSN: 0264-410X, Vol: 38, Issue: 36, Page: 5759-5763
2020
- 11Citations
- 41Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- Captures41
- Readers41
- 41
- Mentions1
- Blog Mentions1
- Blog1
Most Recent Blog
Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial
Vaccine Volume 38, Issue 36 Pages 5741-5876 (10 August 2020) https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36 Research article Abstract only Impact of a decision-aid tool on influenza vaccine coverage among
Article Description
Nosocomial outbreaks of seasonal influenza are frequent, and vaccination is largely recommended for healthcare workers (HCWs). Vaccine coverage in French HCWs does not exceed 20%. Decision-aids (DA) are potential useful interventions to increase vaccine coverage (VC). Our aim was to evaluate the impact of a DA on HCWs influenza vaccine coverage. Prospective cluster-randomized trial conducted in 83 departments in two public hospitals (a teaching and a non-teaching hospital) during the 2018–2019 flu season. Distribution of the DA and of questionnaire about decisional conflict and knowledge in the departments randomized in the intervention group. A total number of 3 547 HCWs were concerned by the study (1 953 in the intervention group, 1 594 in the control group). Global VC was 35.6% during the 2018–2019 season, instead of 23.6% in the 2017–2018 season (p < 0.005). During the 2018–2019 season, VC was 31% (95% CI 28.7–33.3) in the control group and 38.7% (95% CI 36.5–40.9) in the intervention group (p < 0.005). Among the 158 HCWs exposed to the DA who answered the survey, 51.3% had no decisional conflict. HCWs without decisional conflict were more prone to get vaccinated before flu season. The use of the DA was associated with a 25% relative increase in VC among HCWs against seasonal influenza. This modest increase remained far from the WHO 75% target, but may have reduced the number of nosocomial. Multi-component interventions are needed to increase VC in HCWs.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0264410X20309117; http://dx.doi.org/10.1016/j.vaccine.2020.07.011; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85087959447&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/32684500; https://linkinghub.elsevier.com/retrieve/pii/S0264410X20309117; https://dx.doi.org/10.1016/j.vaccine.2020.07.011
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know